Abstract: The invention relates to a method of 13C-MR detection using an imaging medium comprising hyperpolarised 13C-fumarate and imaging media comprising hyperpolarised 13C-fumarate for use in said method.

Abstract: A system and method for metabolic MR imaging of a hyperpolarized agent includes exciting a single metabolic species of a hyperpolarized agent injected into a subject of interest. MR signals are acquired from the excited single metabolic species and an image is reconstructed from the acquired MR signals.

Abstract: A system and method for metabolic MR imaging of a hyperpolarized agent includes exciting a single metabolic species of a hyperpolarized agent injected into a subject of interest. MR signals are acquired from the excited single metabolic species and an image is reconstructed from the acquired MR signals.

Abstract: The invention relates to a method of 13C-MR detection using an imaging medium comprising hyperpolarised 13C acetate and to an imaging medium comprising hyperpolarised 13C-acetate.

Abstract: A system and method are provided for imaging multiple substances, such as contrast agents and metabolites in vivo, with selective excitation frequencies. A first substance is excited with a frequency selective pulse, then a second substance is excited with another frequency selective pulse. The signals resulting from these pulses are acquired in an order reversed from the order in which the pulses were applied. In some embodiments, more than two substances may be imaged. The system and method thus provide for quick and efficient utilization of the magnetization of multiple substances for spectral-spatial imaging.

Abstract: In certain embodiments, methods of the present invention obtain dynamic data sets of an NMR spectroscopy signal of polarized 129Xe in a selected structure, environment, or system. The signal data can be used to evaluate: (a) the physiology of a membrane or tissue; (b) the operational condition or function of a body system or portion thereof (when at rest or under stimulation); and/or (c) the efficacy of a therapeutic treatment used to treat a diagnosed disorder, disease, or condition. Thus, the present invention provides methods for screening and/or diagnosing a respiratory, cardiopulmonary disorder or disease such as chronic heart failure, and/or methods for monitoring the efficacy of therapeutics administered to subject to treat the disorder or disease.

Abstract: The invention relates to hyperpolarised 13C-?-ketoisocaproate, its use as imaging agent, an imaging medium comprising hyperpolarised 13C-?-ketoisocaproate and methods of 13C-MR detection wherein such an imaging medium is used. Further, the invention relates to methods of producing hyperpolarised 13C-?-ketoisocaproate.

Abstract: The invention relates to hyperpolarised 13C-alanine, its use as imaging agent, an imaging medium comprising hyperpolarised 13C-alanine and methods of 13C-MR detection wherein such an imaging medium is used. Further, the invention relates to methods of producing hyperpolarised 13C-alanine.

Abstract: The invention relates to a method of 13C-MR detection using an imaging medium comprising hyperpolarised 13C-fumarate and imaging media comprising hyperpolarised 13C-fumarate for use in said method.

Abstract: The invention relates to a method of 13C-MR detection using an imaging medium comprising hyperpolarised 13C-lactate and to an imaging medium containing hyperpolarised 13C1-lactate for use in said method.

Abstract: A system and method are provided for imaging multiple substances, such as contrast agents and metabolites in vivo, with selective excitation frequencies. A first substance is excited with a frequency selective pulse, then a second substance is excited with another frequency selective pulse. The signals resulting from these pulses are acquired in an order reversed from the order in which the pulses were applied. In some embodiments, more than two substances may be imaged. The system and method thus provide for quick and efficient utilization of the magnetization of multiple substances for spectral-spatial imaging.

Abstract: A system and method are provided for imaging multiple substances, such as contrast agents and metabolites in vivo, with selective excitation frequencies. A first substance is excited with a frequency selective pulse, then a second substance is excited with another frequency selective pulse. The signals resulting from these pulses are acquired in an order reversed from the order in which the pulses were applied. In some embodiments, more than two substances may be imaged. The system and method thus provide for quick and efficient utilization of the magnetization of multiple substances for spectral-spatial imaging.

Abstract: A system and method for metabolic MR imaging of a hyperpolarized agent includes exciting a single metabolic species of a hyperpolarized agent injected into a subject of interest. MR signals are acquired from the excited single metabolic species and an image is reconstructed from the acquired MR signals.

Abstract: A system and method are provided for imaging multiple substances, such as contrast agents and metabolites in vivo, with selective excitation frequencies. A first substance is excited with a frequency selective pulse, then a second substance is excited with another frequency selective pulse. The signals resulting from these pulses are acquired in an order reversed from the order in which the pulses were applied. In some embodiments, more than two substances may be imaged. The system and method thus provide for quick and efficient utilization of the magnetization of multiple substances for spectral-spatial imaging.

Abstract: The present invention provides a method of MR investigation of a sample, said method comprising: (i) nuclear spin polarizing a high T1 MR imaging agent which contains in its molecular structure at least two hyperpolarisable nuclei within the same molecule, the frequency difference between the two resonance lines from said nuclei, ??, being dependent upon either the temperature or the pH of said sample; (ii) administering the nuclear spin polarized MR imaging agent to said sample; (iii) exposing said sample to a radiation at a frequency selected to excite nuclear spin transitions in said MR imaging agent; and (iv) detecting and manipulating magnetic resonance signals from said sample using a single-shot RARE acquisition sequence with shifted data acquisition.

Abstract: In certain embodiments, methods of the present invention obtain dynamic data sets of an NMR spectroscopy signal of polarized 129Xe in a selected structure, environment, or system. The signal data can be used to evaluate: (a) the physiology of a membrane or tissue; (b) the operational condition or function of a body system or portion thereof (when at rest or under stimulation); and/or (c) the efficacy of a therapeutic treatment used to treat a diagnosed disorder, disease, or condition. Thus, the present invention provides methods for screening and/or diagnosing a respiratory, cardiopulmonary disorder or disease such as chronic heart failure, and/or methods for monitoring the efficacy of therapeutics administered to subject to treat the disorder or disease.

Abstract: The present invention provides methods for passive visualisation of invasive devices by employing a hyperpolarised solution of a high T1 agent having a T1 value of at least 5 seconds at a field strength in the range of 0.001-5 T and a temperature in the range of 20-40° C. Devices and instruments particularly useful for being employed in the methods are also provided as well as use of the methods in imaging, surgery and therapy.

Abstract: The present invention provides a method of magnetic resonance imaging of a sample, said method comprising:

Abstract: The invention provides a method of magnetic resonance investigation of a sample, said method comprising: (i) reacting para-hydrogen enriched hydrogen with a hydrogenatable MR imaging agent precursor containing a non-hydrogen non-zero nuclear spin nucleus to produce a hydrogenated MR imaging agent; (ii) administering said hydrogenated MR imaging agent to said sample; (iii) exposing said sample to radiation of a frequency selected to excite nuclear spin transitions of said non-zero nuclear spin nucleus in said hydrogenated MR imaging agent; (v) detecting magnetic resonance signals of said non-zero nuclear spin nucleus from said sample; and (vi) optionally, generating an image or biological functional data or dynamic flow data from said detected signals.

Abstract: In certain embodiments, methods of the present invention obtain dynamic data sets of an NMR spectroscopy signal of polarized 129Xe in a selected structure, environment, or system. The signal data can be used to evaluate: (a) the physiology of a membrane or tissue; (b) the operational condition or function of a body system or portion thereof (when at rest or under stimulation); and/or (c) the efficacy of a therapeutic treatment used to treat a diagnosed disorder, disease, or condition. Thus, the present invention provides methods for screening and/or diagnosing a respiratory, cardiopulmonary disorder or disease such as chronic heart failure, and/or methods for monitoring the efficacy of therapeutics administered to subject to treat the disorder or disease.